Maa: Kanada
Kieli: englanti
Lähde: Health Canada
DOXEPIN (DOXEPIN HYDROCHLORIDE)
AA PHARMA INC
N06AA12
DOXEPIN
75MG
CAPSULE
DOXEPIN (DOXEPIN HYDROCHLORIDE) 75MG
ORAL
100
Prescription
TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS
Active ingredient group (AIG) number: 0107703003; AHFS:
APPROVED
2005-08-03
PRODUCT MONOGRAPH PR SINEQUAN* DOXEPIN HYDROCHLORIDE CAPSULES 10 MG, 25 MG, 50 MG, 75 MG, 100 MG DOXEPIN MANUFACTURER’S STANDARD ANTIDEPRESSANT AND ANXIOLYTIC AA Pharma Inc. Date of Revision: 1165 Creditstone Road, Unit #1 August 31, 2018 Vaughan, Ontario, L4K 4N7 Control No.: 210605 2 ACTION SINEQUAN (doxepin HCl) is a psychotropic agent with antidepressant and anxiolytic properties. It also has sedative and anticholinergic effects, and, in the higher dosage range, it produces peripheral adrenergic blocking effects. Studies of electroencephalograms in humans have shown decreases in amplitude, and amplitude variability, also, the delta, theta and 24-35 CPS activities increased. INDICATIONS The antidepressant and anxiolytic properties of SINEQUAN (doxepin HCl) have been found to be of value in the drug treatment of: 1. Psychoneurotic patients with anxiety and/or depressive reactions; Anxiety neurosis associated with somatic disorders; Alcoholic patients with anxiety and/or depression. 2. Psychotic depression, including manic-depressive illness (depressed type) and involutional melancholia. CLINICAL USE Controlled clinical trials have confirmed that SINEQUAN (doxepin HCl) is an effective psychotropic agent with antidepressant and anxiolytic properties. SINEQUAN has been found useful in alleviating manifest anxiety in neurotic patients including those with somatic disorders. It has also been found useful in patients with neurotic depression, including those with mixed anxiety and depression. Patients with endogenous or psychotic depression, including manic-depressive illness (depressed type), and involutional melancholia, have also been reported to respond favorably to SINEQUAN. As adjunctive medication, it appears to benefit some alcoholic patients with chronic anxiety and depressive reactions. As with most psychotropic agents, some patients with these conditions who have failed to respond to other appropriate medication may benefit from treatment with SINEQUAN. In psychoneurotic patients the following symptoms h Lue koko asiakirja